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Sco1 is implicated in the coppermetallation of the CuA site in
Cox2 of cytochrome oxidase. The structure of Sco1 in the met-
allated and apo-conformers revealed structural dynamics pri-
marily in an exposed region designated loop 8. The structural
dynamics of loop 8 in Sco1 suggests it may be an interface for
interactions with Cox17, the Cu(I) donor and/or Cox2. A series
of conserved residues in the sequencemotif 217KKYRVYF223 on
the leading edgeof this loop are shownpresently to be important
for yeast Sco1 function. Cells harboring Y219D, R220D, V221D,
and Y222D mutant Sco1 proteins failed to restore respiratory
growth or cytochrome oxidase activity in sco1 cells. The
mutant proteins are stably expressed and are competent to bind
Cu(I) andCu(II) normally. Specific Cu(I) transfer fromCox17 to
the mutant apo-Sco1 proteins proceeds normally. In contrast,
using two in vivo assays that permit monitoring of the transient
Sco1-Cox2 interaction, themutant Sco1molecules appear com-
promised in a function with Cox2. The mutants failed to sup-
press the respiratory defect of cox17-1 cells unlike wild-type
SCO1. In addition, the mutants failed to suppress the hydrogen
peroxide sensitivity of sco1 cells. These studies implicate dif-
ferent surfaces on Sco1 for interaction or function with Cox17
and Cox2.
Cytochrome c oxidase (CcO)2 is the terminal enzyme of the
energy-transducing, electron transfer chain within the mito-
chondrial inner membrane (IM). The enzyme contains two
copper centers important for its function (1). One center is the
binuclear copper site (CuA) residing in the Cox2 subunit. The
second center is the CuB site in the Cox1 subunit that forms a
heterobimetallic site with heme a3. The formation of the cop-
per sites in the two mitochondrially encoded subunits occurs
within the mitochondrial intermembrane space (IMS) by a
series of accessory proteins Cox11, Cox17, and Sco1 (2). Cox17
is a soluble Cu(I)-binding protein largely localized within the
IMS. In yeast, CuCox17 appears to specifically transfer Cu(I) to
theCuA site via the IM-tethered Sco1 and to theCuB site via the
IM-anchored Cox11 (3).
The role of Cox17 in formation of the CuA site was initially
implicated from the isolation of SCO1 as a high copy suppressor
of cox17-1 respiratory deficient cells (4). Yeast lacking Sco1 are
devoid of CcO activity and show greatly attenuated Cox2 pro-
tein levels (5, 6). Cu(I) bound to Cox17 can be transferred to
Sco1 through an apparent transient protein-mediated complex.
TheC57Ymutation in the cox17-1 strain precludesCu(I) trans-
fer to Sco1, but not Cox11, consistent with each transfer occur-
ring through a specific protein complex (3). Although attempts
to isolate the Cox17Sco1 complex have failed, a mass spec-
trometry study with human Sco1 and Cox17 revealed a low
abundance ion consistent with a complex (7). Copper metalla-
tion of Sco1 andCox11 is an intermediate step in the transfer of
Cu(I) to Cox2 and Cox1, respectively. One preliminary study
reported an interaction of Sco1 with Cox2 (8), but no direct
interaction has been reported for Cox11 and Cox1.
Unlike yeast, human cells have two functional Sco molecules
that are required for viability (9). Mutations in either human
SCO1 or SCO2 lead to decreased CcO activity and early death.
Studies with immortalized fibroblasts from SCO1 and SCO2
patients suggest that Sco1 and Sco2 have non-overlapping but
cooperative functions in CcO assembly (9). Sco1 and Sco2
localize to the IM and are tethered by a single transmembrane
helix. A globular domain of each exhibiting a thioredoxin fold
protrudes into the IMS (10–13). A single Cu(I) binding site
exists within the globular domain consisting of two cysteinyl
residues within a CX3C motif and a distal conserved histidine
(14, 15). Mutation of the Cys or His residues abrogates Cu(I)
binding and leads to a non-functional CcO complex (14, 16).
The structure predicts that the single Cu(I) ion coordinated to
Sco1 is solvent-exposed and poised for a ligand exchange trans-
fer reaction (17). An additional important aspect of human and
yeastSco1 function is theability tobindaCu(II) ion ina type II-like
sitewith ahigher coordinationnumber than the trigonalCu(I) site
(16). It isunclearwhetherSco1 transfersbothCu(I) andCu(II) ions
to build the mixed valent, binuclear CuA site in Cox2.
A single pedigree was reported with SCO1 mutations that
result in fatal neonatal hepatopathy (18). The afflicted individ-
uals were compound heterozygotes, with a nonsense mutation
on one allele and a P174L missense mutation on the second
allele. SCO1 patient fibroblasts exhibit CcO deficiency along
with a severe cellular copper deficiency (19). This secondary
copper deficiency occurring from enhanced cellular copper
efflux arises from an apparent signaling role of the Sco proteins
that is independent of respiration. The severe deficiency inCcO
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activity in SCO1 patient fibroblasts is partially rescued by over-
expression of the P174Lmutant protein, but the cellular copper
deficiency is only rescued by overexpression of SCO2. The
P174L substitution is adjacent to the second Cys in the Cu(I)-
binding CX3Cmotif in Sco1, yet the mutant protein retains the
ability to bind Cu(I) or Cu(II) when expressed in bacteria. The
molecular defect in the P174Lmutant Sco1 is an impaired abil-
ity to be copper metallated by Cox17 (7, 20). The defect is
attributed to an attenuated interaction with Cox17 (20), in
addition to a modest structural defect that attenuates the Cu(I)
binding affinity (7). Defective Cox17-mediated copper metalla-
tion of Sco1, and subsequent failure of CuA site maturation, is
the basis for the inefficient assembly of the CcO complex in
SCO1 patient fibroblasts.
The role of Sco2 in human CcO assembly remains unclear.
Whereas metallation of human Sco1 is dependent on Cox17
when expressed in the highly chelating environment of the
yeast cytoplasm, metallation of Sco2 occurs independently of
Cox17 (16). Sco2 is suggested to modulate the redox or metal-
lation state of Sco1 (19). Patient mutations in Sco2 pedigrees
map close to either the Cu(I)-binding CX3C motif (E140K) or
the His ligand (S225F). From the structure of human Sco2, the
prediction is that the mutations either attenuate Cu(I) binding
or destabilize the tertiary fold (13). One study confirmed that
E140K substitution perturbed copper binding (21).
The structures of the metal-free human Sco1 and Cu1Sco1
are similar with only one loop (loop 8) showing significant rear-
rangements (17). The movement of this loop orients the Cu(I)
binding His residue at the base of the loop in the proper orien-
tation for metal binding. Although the copper binding site is
somewhat disordered in the apo-conformation, especially the
loop 8 segment, the site is largely preformed poised for Cu(I)
binding (7, 11). The structural dynamics of loop 8 suggests it
may be an important interface for interactions with Cox17
and/or Cox2. Within the loop 8 segment, a series of conserved
residues map to the leading edge of loop 8 and residues preced-
ing the Cu(I) binding His. The tip of loop 8 is devoid of con-
served residues and shows length variation in Sco proteins from
differing species (Fig. 1A).
To elucidate the significance of loop 8 in the function of Sco1,
we carried out mutational analysis of conserved residues in the
loop and evaluated the consequences on metallation by
CuCox17 and interaction with the Cox2 target. We show pres-
ently that a series of functionally important residues at the lead-
ing edge of loop 8 define an interaction site for Cox2 but do not
modulate the Cox17 metallation reaction.
MATERIALS ANDMETHODS
Yeast Strains—Saccharomyces cerevisiae strains used in this
study include the haploid BY4741 wild-type strain (Mat-a,
his31, leu20, met150, ura30), and the isogenic sco1
strain (Mat-a, his31, leu20, met150, ura30, sco1::
KanMX4), both obtained from Research Genetics. The haploid
W303-1A cox17 strain (Mat-, ade2-1, his3-1, 15 leu2-3, 112
trp1-1, ura3-1, cox17::TRP1) was generously provided by Dr.
Alexander Tzagoloff.
Growth Media—Yeast strains cultured in liquid medium
were pre-grown in synthetic complete medium containing 2%
glucose as a carbon source. Pre-cultures were then inoculated
into synthetic complete medium containing 2% raffinose, and
grown to early stationary phase. Yeast plate cultures were
grown on synthetic complete medium or rich medium (yeast
extract and peptone) containing 2% glucose or a 2% glycerol, 2%
lactate mixture (Gly/Lac) as carbon sources. For growth in
exogenous copper, plate culture medium was supplemented
with 1 (synthetic complete) or 8 mM (rich medium) CuSO4.
YeastVectors—ApRS413 (YCp) vector expressing yeastwild-
type SCO1 with a C-terminal HA tag under the control of the
MET25 promoter and CYC1 terminator was utilized as a tem-
plate for generating mutants. All mutants were generated by
site-directed mutagenesis using the Stratagene QuikChange
kit. Additional vectors utilized in this study include a pRS426
(YEp) vector expressing yeast COX19 with a C-terminal Myc
tag under control of theMET25 promoter and CYC1 termina-
tor, as well as a pRS426 (YEp) vector expressing COX17 under
the control of its own promoter and terminator. COX19-Myc
was cut as a BamHI/SalI fragment out of pRS316 (22) and sub-
cloned into pRS426. The COX17 open reading frame including
500 bp of upstream and 500 bp of downstream flanking
sequence was cut as a KpnI/SacI fragment from pRS316 (23)
and subcloned into pRS426. pLacIII (YCp) vectors expressing
COX17 (23) or a CYB2-C57Y COX17 under control of the
MET25 promoter and CYC1 terminator were also used. The
CYB2-C57Y COX17 was cut from pRS316 (23) as a KpnI/SacI
fragment and subcloned into pLacIII. SCO1 Cys mutants were
expressed in the pRS424 (YEp) vector under control of the
SCO1 promoter and terminator (14). Wild-type hSCO1 cloned
into theGateway-modified retroviral expression vector pLXSH
was used as a PCR template for cloning hSCO1 into a yeast
vector. The 3 oligonucleotide PCR primer removed the stop
codon from the hSCO1 open reading frame and added a coding
sequence for a C-terminal Myc tag. hSCO1-Myc PCR product
was cloned into pRS426 under the control of the MET25 pro-
moter and the CYC1 terminator. The hSCO1 P174L mutant
allele was generated by site-directed mutagenesis using the
StratageneQuikChange kit. Sequencingwas used to confirm all
cloning and mutagenesis.
Protein Purification—The Escherichia coli expression vector
pHis-Parallel2 containing His6-tagged-soluble SCO1 was used
as a template to generate the 4 non-functional SCO1mutants
(14). Mutant alleles were generated by site-directed
mutagenesis using the Stratagene QuikChange kit. All
mutants were verified by sequencing. pHis-Parallel2 vectors
containing wild-type or mutant His6-soluble SCO1 were
transformed into competent BL21(pLysS) E. coli. Transfor-
mants were pre-grown at 37 °C to A600 0.6, induced by the
addition of 0.45 mM isopropyl 1-thio--D-galactopyrano-
side, and incubated for an additional 4 h at 30 °C. For puri-
fication of the copper-loaded protein, CuSO4 was added to
the culture medium 15 min prior to induction, to a final
concentration of 1 mM. Cells were harvested, washed, and
then resuspended in PBS containing 10 mM imidazole and 1
mM DTT. Cells were lysed by freeze-thawing followed by
repeated sonication. Lysates were cleared by centrifugation
at 50,000  g for 30 min at 4 °C. Supernatants were loaded
onto 10-ml nickel-NTA Superflow (Qiagen) columns. After
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loading, columns were washed three times: first with PBS
containing 10 mM imidazole and 1 mM DTT, followed by
washes with PBS containing 20 mM imidazole and 1 mM
DTT, and 2 times with PBS containing 20 mM imidazole and
1 mM DTT. Purified His-tagged Sco1 proteins were eluted
with PBS containing 250 mM imidazole and 1 mMDTT. Puri-
fied proteins were concentrated to the desired volume in a
5000-Da cut-off Vivaspin 20 (VivaScience) spin column. To
monitor protein purification, purification fractions (load,
flow-through, washes, and elution) were analyzed by SDS-
PAGE on a 15% polyacrylamide gel and visualized by Coo-
massie staining. Copper concentrations were determined for
the same purification fractions using a PerkinElmer Life Sci-
ences AAnalyst 100 atomic absorption spectrophotometer.
Pure, concentrated protein was subjected to 12 h dialysis in
PBS containing 1 mM DTT at 4 °C using a Slide-A-Lyzer
dialysis cassette with a 3500-Da cut-off membrane. Wild-
type His-tagged Sco1 protein was purified side by side (in
parallel) with each mutant protein. Proteins were quantified
by amino acid analysis on a Hita-
chi L-8800 analyzer after hydroly-
sis in 5.7 N HCl containing 0.1%
phenol in vacuo at 110 °C.
CuCox17 protein used for in vitro
transfer assays was purified as
described previously (3). Apo-His-
Sco1was generated by incubation of
pure protein with KCN for 30 min,
followed by desalting into PBS using
Bio-Gel P6 resin (Bio-Rad). In vitro
Cu(I) transfer assays were per-
formed as previously described (3).
Spectroscopy—Copper concen-
trations in protein samples were
measured using a PerkinElmer Life
Sciences AAnalyst 100 atomic
absorption spectrophotometer or
a PerkinElmer Optima 3100XL
inductively coupled plasma optical
emission spectrometer. Absorption
spectra were recorded on a Beck-
manDU640UV-visible spectropho-
tometer. Luminescence was meas-
ured on a PerkinElmer Life Sciences
LS55 spectrometer with an excita-
tion wavelength of 300 nm, moni-
toring emission from350 to 700 nm.
Excitation and emission slit widths
were set at 5 and 15 nm, respec-
tively, using a 350-nm band pass
filter.
Isolation of Mitochondria and
Oxidase Activity—Mitochondria were
isolated according to the method
described previously (24) in the
presence of 1 mM phenylmethylsul-
fonyl fluoride. Mitochondrial pro-
tein concentrations were quantified
by Bradford assay (25). CcO enzymatic activity in isolatedmito-
chondria (5–10g of protein)was quantified bymonitoring the
oxidation of 32 M reduced equine heart cytochrome c at 550
nm in 40 mM KH2PO4, pH 6.7, 0.5% Tween 80.
Immunoblotting Analysis—40 g of mitochondrial protein
was loaded onto a 15% polyacrylamide gel, separated by SDS-
PAGE, and transferred to a nitrocellulose membrane. Mem-
branes were probed with the indicated primary antibody and
visualized with ECL reagents (Pierce), following incubation
with a horseradish peroxidase-conjugated secondary antibody.
Mouse monoclonal anti-HA and anti-Myc antibodies were
obtained from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA). Antisera to the mitochondrial OM porin (Por1) was
obtained fromMolecular Probes, Inc. (Eugene, OR).
Hydrogen Peroxide Treatment of Yeast Cells—Cells were
grown in synthetic complete medium containing 2% glucose
at 30 °C, to mid-exponential phase. Hydrogen peroxide was
added to a final concentration of 1 or 6 mM, followed by a 2-h
incubation at 30 °C. Cells were then serially diluted and
FIGURE 1.Mutagenized loop 8 segment of Sco proteins. Panel A, sequence alignment of Sco protein in the
loop 8 region with numbering in reference to the yeast Sco1. The underlined residues in bold are the four
residues that when mutated result in loss of function. Panel B, the two conserved segments of loop 8 are
highlighted in black. The mutated residues lie on the leading edge of loop 8 (shown by the dashed arrow 1),
whereas the conserved residues adjacent to the Cu(I) binding His residue (shown by ‡ in panel A) are in black
with a dashed arrow 2. The Cu(I) ion is shown as a black sphere. Panel C, the YRVY motif important for Cox2
interaction is shown in black along with the Pro mutated in human Sco1 (P174L) that abrogates Cu(I) metalla-
tion by Cox17.
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plated into rich medium plates containing 2% glucose (YPD)
(26).
RESULTS
Mutational Analysis of Loop 8 in Yeast Sco1—A comparison
of Sco1 proteins from diverse eukaryotes reveals two conserved
segments in the prominently solvent-exposed loop 8 that
exhibits structural dynamics between the metallated and apo-
conformers. One segment consisting of 233QDYLVDH239
(numbering based on the yeast Sco1 sequence) is adjacent to the
Cu(I) binding His239 residue (Fig. 1B). We showed previously
that neitherGln233 norAsp234was important for Sco1 function,
but Asp238 was functionally important and influenced Cu(II)
binding to Sco1 (16). Presently, we focused on the conserved
sequence motif 217KKYRVYF223 preceding loop 8 (Fig. 1B). To
elucidate the significance of loop 8 in the function of Sco1, we
carried out mutational analysis of conserved residues in this
segment.
Single codon mutations were generated at seven positions
from the loop 8 base toward the loop tip. Asp substitutionswere
made at most positions to alter the chemical functionality at
that position. The rationale was that if the conserved motif
served as an interaction site for Cox17 and/or Cox2, a change in
chemical functionality would have a more dramatic effect than
an Ala substitution. Three of the Sco1 substitution mutants
were functional when expressed in sco1 cells (Fig. 2A). The
K217D, S224A, and K230A alleles
enabled sco1 cells to propagate
on glycerol/lactate medium and
assemble a functional CcO enzyme
(Fig. 2, A and B), although CcO oxi-
dase activity was attenuated with
the K217D mutant cells. Growth of
yeast cells on glycerol/lactate
medium can occur in cells with
30% of wild-type CcO activity. In
contrast, four Sco1mutants failed to
rescue glycerol/lactate growth in
the sco1 cells (Fig. 2A). Cells har-
boring Y219D, R220D, V221D, and
Y222D mutant Sco1 proteins did
not propagate on glycerol/lactate
medium and had attenuated CcO
activities (Fig. 2C). The substitu-
tions did not destabilize the protein.
The four mutant proteins were sta-
bly expressed (Fig. 2B), suggesting
that the function of Sco1 was com-
promised by the substitutions. The
non-functional mutants have no
dominant negative effects when
expressed in wild-type yeast cells
(data not shown).
Because Sco1 is implicated in
copper metallation of Cox2, we
tested whether the lack of glycerol/
lactate growth in sco1 cells
expressing Y219D, R220D, V221D,
and Y222D mutants was suppressed by supplemented copper
salts (Fig. 2D). The respiratory deficiency of cells lacking Cox17
is weakly suppressed by high exogenous copper salts in rich
growth medium (4). Supplemental copper salts cannot confer
growth of sco1 cells (4), but partial growth was restored in
sco1 cells harboring Y219D, R220D, and V221D, but not
Y222D mutant alleles when plated on rich medium with glyc-
erol/lactate as carbon sources. With copper-supplemented
synthetic medium with glycerol/lactate, only the V221D
mutant Sco1 enabled partial growth (data not shown).
The only non-functional patient mutation in human Sco1
identified to date is the P174L substitution adjacent to the
Cu(I)-binding CX3C motif (18). The molecular defect in P174L
Sco1 appears confined to the interaction with Cox17, and ele-
vated Cox17 levels can restore Cu(I) transfer in vitro (20). We
tested whether overexpression of COX17 would enhance glyc-
erol/lactate growth of sco1 cells harboring the nonfunctional
mutants (supplemental Fig. S1). The presence of elevated
Cox17 levels enhanced growth only of sco1 cells containing
the V221D mutant consistent with the suppression by exoge-
nous copper. Overexpression of the Cox17-related IMS protein
Cox19 failed to confer growth in combination with any of the
four mutant alleles (data not shown).
Respiratory-deficient Loop 8 Mutants Bind Cu(I)/Cu(II)
Normally and Are Not Impaired in Cu(I) Metallation by
FIGURE 2. Functionality of Sco1 mutants. Panel A, serial dilution of BY4741 sco1 cells containing low copy
plasmid SCO1 encoding wild-type or mutant alleles of Sco1-HA as indicated on glucose and glycerol/lactate
medium (synthetic complete medium). Panel B, steady-state levels of Sco1-HA and Sco1-HA mutants were
assessed by immunoblotting of mitochondrial fractions from corresponding strains. Mitochondrial fractions
wereprobedwith anti-HAantibody. Por1wasusedas amitochondrialmarker and loading control.Panel C, CcO
enzymatic activities on mitochondria isolated frommutant strains. Activities are expressed as percent of CcO
activity in wild-typemitochondria. Panel D, growth test of sco1 cells harboring various sco1 alleles for copper
suppression. Non-functional Sco1-HA mutants were tested for suppression of their phenotype by growth on
glycerol/lactate (richmedium) supplemented with 8mM CuSO4 (glucose loading control not shown). Copper-
binding Sco1 mutants (C148A, C152A, and C148A,C152A) were used as negative controls. Serial dilutions of
cells were plated.
Sco1-Cox2 Interaction Interface
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Cox17—The four non-functional Sco1 mutants were recom-
binantly expressed in bacteria to evaluate their copper binding
properties. N-terminal truncates of the Sco1 mutants were
expressed and purified as soluble proteins, as previously
described (14, 16). Sco1 purified from E. coli cultures supple-
mented with exogenous copper salts results in the isolation of
Cu(I)-bound Sco1 (14, 16). The Cu(I) complex with wild-type
Sco1 is stable to dialysis. Purification of the Y219D, R220D,
V221D, and Y222D mutant proteins followed by dialysis
revealed that each mutant retained the ability to bind Cu(I)
(Table 1). In addition, each mutant Sco protein retained the
ability to bind Cu(II) as shown by the S-Cu(II) charge transfer
bands (Fig. 3 andTable 1). Thus, themutations did not abrogate
copper binding.
A series of assays were performed to assess whether the non-
functional mutations abrogated a functional interaction with
Cox17.Wedemonstrated previously that specificCu(I) transfer
fromCox17 to Sco1 occurs in both in vitro and in vivo reactions
(3). We used the in vitro Cu(I) transfer assay to assess the effi-
ciency of Cox17-mediated Cu(I) transfer to Sco1. Incubation of
CuCox17with apo-Sco1 results in a time-dependent transfer of
Cu(I) to Sco1 as assessed by the loss of emission of the Cu(I)-
thiolate coordination in Cox17 (Fig. 4A) (3). The emission of
CuCox17 is stable when incubated with CuSco1 or heterolo-
gous molecules. We showed previously that CuCox17 with a
C57Y substitution, which does not alter Cu(I) binding, fails to
transfer Cu(I) to apo-Sco1. In contrast, incubation of wild-type
CuCox17with equimolar Y219D and Y222Dmutant Sco1mol-
ecules showed similar kinetics of Cu(I) transfer as the wild-type
Sco1 suggesting that the mutations did not attenuate Cu(I)
transfer from Cox17 (Fig. 4B). The V221D Sco1 mutant also
exhibited wild-type kinetics of Cu(I) transfer from CuCox17
(data not shown). This in vitro assay suggests that the mutant
and wild-type Sco1 molecules have an equivalent affinity for
Cu(I).
Loop 8 Mutants Are Impaired in Sco1 Function with Cox2—
Overexpression of Sco1 was shown to partially suppress the
respiratory deficiency of cox17-1mutant cells, but suppression
of cox17 cells required the presence of supplementalCuSO4 in
addition to overexpression of SCO1 (4). To bypass Cox17, high
copy Sco1must facilitate its ownmetallation and that of Cox11
for the subsequent metallation of Cox1 and Cox2, respectively.
FIGURE 3. Absorption spectroscopy of CuSco1 (Y219D). The absorption
spectrumof recombinant, purifiedHis-taggedCuSco1Y219D reveals thenor-
mal Cu(II) chromophore transitions in the visible region with maxima at 360
and 480 nm. All mutants purified exhibited transitions representative of the
wild-type protein, confirming the ability of the mutants to bind Cu(II) nor-
mally. The inset shows the entire absorption spectrum of the Cu-Sco1
(Y219D).
FIGURE 4. Cox17-mediated Cu(I) transfer to apo-Sco1 and mutant Sco1
molecules. Panel A, CuCox17 (45 mM copper) was incubated with 50 mM
wild-type or mutant apo-Sco1 for 10 min at room temperature. The lumines-
cence of CuCox17 before and after the addition of either wild-type apo-Sco1
or theY219Dmutant is shown. The loss of luminescenceobserveduponaddi-
tion of apo-Sco1 Y219Dwas representative of all other mutants tested. Panel
B, the kinetics of Cox17-mediated copper transfer to apo-Sco1 is shown. The
loss of luminescence was monitored upon addition of either wild-type or
mutant apo-Sco1. The total copper transferred was taken as the total loss of
luminescence, whereas the fraction of total copper transferred was calcu-
lated by loss of luminescence at any given time point, over total loss of lumi-
nescence. The controls include CuCox17 alone (No Add.), as well as the addi-
tion ofmetallated, Cu-Sco1 (Cu-Sco1). The Sco1 V221Dmutant (not shown)
demonstrated similar kinetic loss of luminescence.
TABLE 1
Copper binding stoichiometries of Sco1 mutants
Recombinant soluble His-Sco1 mutant proteins were purified from E. coli cultured
in medium containing supplemental copper. Copper per protein stoichiometries
weremeasured from protein samples as purified, following concentration, as well as
12 h dialysis. Cu(II) binding was assessed by comparing A360 of mutants to A360 of
wild-type His-Sco1 at the same protein concentrations.
Cu/protein WTSco1
Y219D
Sco1
R220D
Sco1
V221D
Sco1
Y222D
Sco1
Elution 1.0 0.1 1.0 0.1 0.9 0.1 0.9 0.1 0.9 0.1
Concentration 1.0 0.1 1.1 0.1 0.9 0.1 0.8 0.1 0.8 0.1
Post-dialysis 0.9 0.1 0.9 0.1 0.8 0.1 0.7 0.1 0.7 0.1
 Cu(II)/WT  Cu(II) 1.0 1.0 0.9 0.8 1.1
Sco1-Cox2 Interaction Interface
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We tested whether Y219D, R220D, V221D, and Y222D Sco1
mutants retained the ability to suppress the respiratory defect
of cox17-1 cells. If the mutations abrogated Cox17-mediated
metallation, the prediction is that the mutants would be func-
tional as the wild-type Sco1. Alternatively, if the mutations
abrogate the function of Sco1 in CuA site formation in Cox2,
then overexpression of themutant proteins would fail to confer
respiratory growth to cox17-1 cells. Episomal wild-type SCO1
transformants of cox17-1 cells enabled the cells to propagate on
glycerol/lactate medium, whereas episomal mutant SCO1 alle-
les encoding each of the four substitutions failed to confer
growth (Fig. 5). These results suggest that the mutations atten-
uate the interaction of Sco1 with Cox2.
Multiple attempts were made to document a physical inter-
action of Sco1 and Cox2. The sco1 cells expressing the loop 8
mutants lack stable Cox2, therefore immunoprecipitation was
attempted from mitochondria of wild-type cells co-expressing
the mutant proteins. We observed variable results with wild-
type Sco1 limiting our ability to reproducibly quantify the levels
of Sco1 interacting with Cox2 with either the HA-tagged wild-
type or mutant Sco1 molecules. Detergent-solubilized Sco1
fractionates as a highmass complex, but the size of the complex
is independent of the presence of Cox2 (14). The same conclu-
sion was reached in monitoring the migration of Sco1 on blue-
native PAGE after in vitro import of Sco1 translated in a rabbit
reticulocyte lysate with [35S]cysteine in mitochondria of wild-
type cells compared with cox2 cells. In both cases, Sco1
migrated as a 300-kDa major complex (data not shown).
Thus, the more direct assays to quantify a Sco1-Cox2 interac-
tion were not informative.
Cells lacking Sco1 are sensitive to hydrogen peroxide (28).
We demonstrated that peroxide sensitivity of sco1 cells arises
from the transient accumulation of a pro-oxidant heme
a3:Cox1 stalled intermediate (26). The peroxide sensitivity of
sco1 cells is suppressed by the addition of either wild-type or
Cys mutant alleles of Sco1 that fail to bind Cu(I). We proposed
that the lack of Sco1 destabilizes Cox2 sufficiently that it fails to
interact with Cox1 leading to peroxide sensitivity. We tested
the loop 8 Sco1 mutants for their ability to suppress hydrogen
peroxide sensitivity of sco1 cells (Fig. 6A). Whereas the wild-
type Sco1 protein effectively suppresses the hydrogen peroxide
sensitivity of sco1 cells, the addition of the Y219D, R220D,
V221D, and Y222D alleles failed to confer peroxide resistance.
Curiously, two mutant alleles, K217D and K230D, that confer
glycerol/lactate growth in sco1 cells are partially compro-
mised in their ability to confer peroxide resistance. In contrast,
as shown previously, respiratory-defective mutants Sco1 com-
promised in Cu(I) binding (C148A and C152A mutant Sco1)
are fully competent to suppress hydrogen peroxide sensitivity
(Fig. 6A). Cys mutants of Sco1 were shown to retain the ability
to bind Cox2 (8). Suppression of the hydrogen peroxide sensi-
tivity of sco1 cells by Sco1 variants is dependent on the Sco1
transmembrane domain. Replacement of the transmembrane
segment by the transmembrane fromCox11 failed to generate a
chimera active in suppression of peroxide sensitivity (data not
shown).
Human Sco1 that is nonfunctional in yeast CcO assembly is
also able to suppress the peroxide sensitivity of yeast sco1 cells
(26). The P174L mutation in human Sco1 that attenuates cop-
per transfer from Cox17 (20) confers resistance to yeast sco1
cells to hydrogen peroxide (Fig. 6B). Both wild-type and P174L
Sco1 proteins are equivalently expressed (Fig. 6C).
DISCUSSION
The conversion of apo-Sco1 to the Cu(I) conformer is
accompanied by only structural rearrangements of a protrud-
ing loop that orients the Cu(I) binding His residue (17). The
prominent exposure of loop 8 in the Sco1 structure was con-
sistent with a candidate role as an interaction interface with
either its Cu(I) donor Cox17 and/or its Cu(I) target Cox2. We
show presently that aspartate substitutions at four conserved
positions at the start of loop 8 compromise the function of yeast
Sco1. Cells harboring Y219D, R220D, V221D, and Y222D
mutant Sco1 proteins failed to restore glycerol/lactate growth
or CcO activity in sco1 cells. The mutant proteins are stably
expressed and are competent to bindCu(I) andCu(II) normally.
These conserved resides at the leading edge of loop 8 appear
to define a functionwithCox2 but are less important for Cox17.
The respiratory defect of the Y219D, R220D, V221D, and
Y222D mutant cells was not rescued by overexpression of
COX17, unlike the P174L mutant Sco1 that is compromised in
Cu(I) transfer by Cox17. However, elevated Cox17 levels had a
FIGURE 5. Suppression of cox17-1 and cox17 cells. Panel A, SCO1mutant
alleles were tested for their ability to suppress the cox17-1 growth defect on
glycerol/lactate medium. W303-1A cox17 cells harboring plasmid-encoded
Cyb2-C57Y Cox17 were transformed with wild-type or mutant SCO1 alleles
and subsequently assessed for growth on glucose (synthetic complete) and
glycerol/lactate (synthetic complete  1 mM CuSO4, and rich, YP glycerol/
lactate). Serial dilutions of cells were plated. Panel B, the same Sco1 mutants
were tested as in panel A in cox17 cells cultured in synthetic complete glu-
cose, and YP-glycerol/lactate 8 mM CuSO4.
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modest stimulatory effect with theV221Dmutant Sco1. In vitro
Cu(I) transfer studies with CuCox17 and purified mutant pro-
teins suggest that Cox17-mediated metallation of Sco1 pro-
ceeds normally with the four mutant Sco1 proteins. Two lines
of evidence suggest that themutant proteins are impaired in the
function with its target Cox2. The two assays indirectly report
on the transient Sco1-Cox2 interaction. The first assay involves
the known suppression of the respiratory deficiency of cox17-1
cells by high copy Sco1 (4). The mechanism of suppression is
likely the ability of high levels of Sco1 protein to bypass the
impaired copper metallation of Sco1 by the C57Y mutant
Cox17 and subsequent Sco1-mediated metallation of Cox2.
With the first assay we show that the Y219D, R220D, V221D,
and Y222D substitutions abrogate the ability of Sco1 to sup-
press the respiratory defect of cox17-1 cells. The high copy
Y219D, R220D,V221D, andY222Dmutant Sco1 proteins fail to
suppress even in cox17-1 cultures supplemented with 1 mM
exogenous copper.
The second assay involves the hydrogen peroxide sensitivity
of sco1 cells that can be suppressed by certain non-functional
Sco1mutants (26). Copper-binding yeast Sco1mutants (C148A
and C152A mutants) and wild-type human Sco1 confer perox-
ide resistance to sco1 cells without supporting CcO biogene-
sis. We anticipate that in the absence of Sco1, Cox2 is compro-
mised in its interactionwithCox1 allowing accumulation of the
pro-oxidant heme a3:Cox1 intermediate. Heme a/a3 insertion
likely occurs in Cox1 prior to the addition of Cox2 in the bio-
genesis of CcO. Cox2 packs onto the partially accessible face of
Cox1 that may be the site of hemes a/a3 insertion prior to Cox2
docking. CcO assembly mutants that block Cox2 addition to
the preassembly Cox1 containing hemes a/a3 are peroxide sen-
sitive. With the second assay, we observe that the loop 8
mutants fail to reverse hydrogen
peroxide sensitivity of sco1 cells.
The inability of the Y219D, R220D,
V221D, and Y222D mutant Sco1
proteins to reverse the peroxide
sensitivity of sco1 cells cannot
arise from the non-functional status
of these mutants as the non-func-
tional C148A and C152A Sco1
mutants compromised in Cu(I)
binding do restore peroxide resist-
ance. The K217D and K230D
mutants that restore limited CcO
activity in sco1 cells also confer
limited peroxide resistance.
The P174L Sco1 patientmutation
ismore impaired in its functionwith
Cox17 than Cox2, whereas the four
loop 8 mutants are more compro-
mised with Cox2. Consistent with
this conclusion is the observation
that P174L Sco1 confers peroxide
resistance to sco1 cells unlike the
Y219D, R220D, V221D, and Y222D
mutant Sco1 proteins. Pro174 in
human Sco1 corresponds to yeast
Pro153. Pro153 and loop 8 segment encompassingTyr219–Tyr222
are on distinct faces of Sco1 (Fig. 1C) leading to the possibility
that Sco1 uses distinct interfaces for interaction with Cox17
and Cox2. However, some overlap may exist as the V221D
mutant Sco1 that is compromised in its interaction with Cox2,
also shows a modest enhancement in function with high copy
Cox17. The entire loop 8 does not appear to be an interaction
interface as the loop tip shows no sequence conservation and
significant length variation occurs (Fig. 1A).
A neutral surface on Sco1 was predicted previously to be an
interface for Cox2 without supporting evidence. The surface
implicated involved human Sco1 Thr261 and residues 169–172
of the CPDV sequence (11). Pro174 is also prominent on that
surface and based on the present studies, we predict that the
neutral surface mentioned is more important in the transient
interaction with Cox17 than Cox2. In a study comparing Cu(I)
transfer to human Sco1 from CuCox17 versus Cu(I) acetoni-
trile, differential perturbations in residues 258–262 were
observed in 1H-15N-HSQC spectra. Those residues are spa-
cially close to the surface defined by residues 169–174 (7).
Thus, the surface of human Sco1 consisting of residues 169–
174 and 258–261 may be important for Cox17 interaction.
Because the residues implicated in this study for Cox2 function
(minimally residues 241–245 of human Sco1) lie on an adjacent
face of Sco1, an intriguing possibility exists that a tertiary com-
plex of Cox17, Sco1, and Cox2 may form for the Cu(I) transfer
steps. The weak suppression seen by overexpression of Cox17
with the V221D Sco1 mutant in sco1 cells may arise from a
stabilizing effect of Cox17 on the V221D Sco1-Cox2 transient
interaction.
A significant challenge remains to obtain a soluble Cox2
domain for detailed analysis of the copper transfer reaction. In
FIGURE 6. Sensitivity of sco1 transformants to hydrogen peroxide. SCO1 mutant alleles were tested for
their sensitivity to hydrogen peroxide exposure. Panel A, BY4741 sco1 cells expressing wild-type or mutant
Sco1-HA were grown to mid-exponential phase and incubated with () or without (	) 1 or 6 mM H2O2 for 2 h
at 30 °C. Respective serial dilutions were plated onto rich medium containing 2% glucose (YPD) for growth
assessment. Panel B, BY4741 sco1 cells expressing hSco1 or hSco1 P174L mutant were grown and treated as
in A. Panel C, steady-state levels of hSco1 and hSco1 P174L were assessed by immunoblotting mitochondrial
fractions from corresponding strains. Mitochondrial fractions were probedwithMyc antisera to detect human
Sco1-Myc. Por1 was used as a mitochondrial marker and loading control.
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the absence of available Cox2 for in vitro studies, one cannot be
certain that the transfer of Cu(I) from Sco1 to Cox2 proceeds
directly without the participation of another assembly factor
such as Cox20 that is implicated as a Cox2 chaperone (27).
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Supplemental Fig. 1
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